Track Roivant Sciences's accounts payable ($18M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), ROIV shows a accounts payable of $18M. That compares with $24M in the prior-year period — down 24.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ROIV's accounts payable is now $18M (was $24M) — a 24.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Roivant Sciences is outperforming or lagging.
Tracking ROIV's accounts payable over time shows whether Roivant Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $18M That compares with $24M in the prior-year period — down 24.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this accounts payable page, Stockcircle has Roivant Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $18M) with ownership activity and broader fundamentals.